Risperidone induced amenorrhea and galactorrhea in a case of an adolescent patient
Galactorrhea and amenorrhea are known risks of risperidone, given risperidone’s blockade of dopamine D2 receptors and subsequent risk of prolactin elevation, and this paper presents the case of an adolescent female patient who developed reversible amenorrhea and galactorrhea after being treated with...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-01-01
|
Series: | Cogent Medicine |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2331205X.2017.1328819 |